Found 5 matching trials
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma PHASE2 This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma PHASE3 The study evaluated the overall survival (OS) of SHR-A1904 versus investiga...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer PHASE2 This is a multicenter, Phase 2 clinical trial to evaluate the efficacy and ...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma PHASE2 This is a prospective, single-center, phase II trial designed to evaluate t...
Show More Location
Beijing GoBroad Hospital
Learn More & Join Trial
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer PHASE2 This is a multi-cohort, multi-center Phase II clinical study exploring the ...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial